Quick Answer
UPEXI, INC. reported Cash and Equivalents of $7.15 million for fiscal year 2022.
UPEXI, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2022 | $7.15M | -50.8% |
| 2021 | $14.53M | +1537.6% |
| 2020 | $887.5K | -76.0% |
| 2019 | $3.70M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| March 31, 2022 | $4.50M | +112.6% | -31.7% |
| December 31, 2021 | $6.60M | +450.6% | -49.4% |
| September 30, 2021 | $13.03M | +2460.8% | -10.3% |
| June 30, 2021 | $14.53M | +1537.6% | +586.2% |
| March 31, 2021 | $2.12M | — | +76.8% |
| December 31, 2020 | $1.20M | — | +135.4% |
| September 30, 2020 | $509.0K | — | -42.6% |
| June 30, 2020 | $887.5K | — | — |
- UPEXI, INC. showed a decrease of -50.8% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2019–2022 period, UPEXI, INC.’s cash and equivalents has grown by 93.4% (from $3.70 million to $7.15 million).
- The most recent figure is from UPEXI, INC.’s fiscal year 2022 report (Form 10-K), filed with the SEC on September 28, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: